17 β-Estradiol alleviates synergistic oxidative stress resulting from folate deprivation and amyloid-β treatment

Journal of Alzheimer's Disease

Volumn 5, Issue 4, 2003, Pages 323-327

  Shea, Thomas B ^a   Ortiz, Daniela ^a  

^a University of Massachusetts Lowell   (United States)

Author keywords

Alzheimer's disease; Antioxidants; Estradiol; Folate A ; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; FOLIC ACID; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; NERVE CELL CULTURE; NERVE CELL NECROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; VITAMIN DEFICIENCY;

EID: 0242467828     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2003-5408     Document Type: Article

References (36)

1. R.H. Allen, S.P. Stabler and J. Lindenbaum, Eur J Pediatr 157 (1998), S122-S126.
2. A.B. Bonnefont, F.J. Munoz and N.C. Inestrosa, Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes, FEBS Lett 441 (1998), 220-224.
3. R. Clarke, A.D. Smith, K.A. Jobst, H. Refsum, L. Sutton and P.M. Ueland, Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease, Arch Neurol 55 (1998), 1449-1455.
4. J.A. Collins, C.A. Schandi, K.K. Young, J. Vesely and M.C. Willingham, Major DNA fragmentation is a late event in apoptosis, J Histochem Cytochem 45 (1997), 923-934.
5. F.J. Ekinci, M.-D. Linsley and T.B. Shea, beta-amyloid-induced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation, Mol Brain Res 76 (2000), 389-395.
6. F.J. Ekinci, K.M. Malik and T.B. Shea, beta-amyloid induces calcium influx and neurodegeneration by MAP kinase-mediated activation of the L voltage-sensitive calcium channel, J Biol Chem 274 (1999), 30322-30327.
7. Y. Goodman, A.J. Bruce, B. Cheng and M.P. Mattson, Estrogens attenuate and corticosterone exacerbates excitotoxicity oxidative injury amyloid b-peptide toxicity in hippocampal neurons, J Neurochem 66 (1996), 1836-1844.
8. G.E. Gray, Nutrition and dementia, J Am Diet Assoc 89 (1989), 1795-1802.
9. K.E. Gridley, P.S. Green and J.W. Simpkins, A novel, synergistic interaction between 17 β-estradiol and glutathione in the protection of neurons against b-amyloid 25-35-induced toxicity in vitro, Mol Phann 54 (1998), 874-880.
10. C. Haas, M.G. Schlossmacher, A.Y. Hung, C. Vigo-Pelfrey, A. Mellon, B.L. Ostaszewski, I. Lieberburg, E.H. Koo, D. Schenk, D.B. Teplow and D.J. Selkoe, Amyloid peptide is produced by cultured cells during normal metabolism, Nature 359 (1992), 149-163.
11. L. Hassing, A. Wahlin, B. Winblad and L. Backman, Further evidence on the effects of vitamin B12 and folate levels on episodic memory functioning: a population-based study of healthy very old adults, Biol Psychiatry 45 (1999), 1472-1480.
12. P. Ho, S.C. Collins, S. Dhitavat, D. Ortiz, D. Ashline, E. Rogers and T.B. Shea, Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress, J Neurochem 78 (2001), 249-253.
13. P.I. Ho, D. Ortiz, E. Rogers and T.B. Shea, Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage, J Neurosci Res 70 (2002), 694-702.
14. P. Ho, D. Ashline, S. Dhitavat, D. Ortiz, S.C. Collins, E. Rogers and T.B. Shea, Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine, Neurobiol Dis: in press, 2003.
15. J. Tan, T. Town, A. Placzek, A. Kundtz, H. Yu and M. Mullan, Bcl-X(L) inhibits apoptosis and necrosis produced by Alzheimer's beta-amyloid1-40 peptide in PC12 cells, Neurosci Lett 272 (1999), 5-8.
16. I.I. Kruman, C. Culmsee, S. Chan, Y. Kruman, Z. Guo, L. Penix and M.P. Mattson, Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity, J Neurosci 20 (2000), 6920-6926.
17. I.I. Kruman, T.S. Kumaravel, A. Lohani, W.A. Pedersen, G. Roy, R.G. Cutler, Yuri Kruman, N. Norman Haughey, J. Lee, M. Michele Evans and M.P. Mattson, Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease, J. Neurosci. 22 (2002), 1752-1762.
18. M.M. Mattson and T.B. Shea, Folate Folate and Homocysteine in Neural Plasticity and Neurodegenerative Disorders, Trends in Neurosciences: in press, 2002.
19. K. Nilsson, L. Gustafson, R. Faldt, A. Anderson and B. Hultberg, Plasma homocysteine in relation to serum cobalamin and blood folate in a psychogeriatric population, Eur J Clin Inves 24 (1994), 600-606.
20. H. Nilsson-Ehle, Age-related changes in cobalamin (vitamin B12) handling, Implications for therapy. Drugs Aging 12 (1998), 277-292.
21. B. Regland, K. Blennow, T. Germgard, A.-C. Kock-Schmidt and C-G. Gottfries, The role of the polymorphic genes Apolipoprotein E and Methylene-tetrahydrofolate reductase in the development of dementia of the Alzheimer type, Dement Geriatr Gogn Disord 10 (1999), 245-251.
22. M.J. Renvall, A.A. Spindler, J.W. Ramsdell and M. Paskvan, Nutritional status of free-living Alzheimer's patients, Am J Med Sci 298 (1989), 20-27.
23. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N Engl J Med 336 (1997), 1216-1222.
24. J.M. Serot, D. Christman, T. Dubost, M.C. Bene and G.C. Faure, CSF-folate levels are decreased in late-onset AD patients, J Neural Transm 108 (2001), 93-99.
25. P. Seubert, C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, D. Sinha, M. Schlossmacher, J. Whaley, C. Swindlehurst, R. McCormack, R. Wolfert, D. Selkoe, I. Liebergurg and D. Schenk, Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids, Nature 359 (1992), 325-237.
26. T.B. Shea and E. Rogers, Homocysteine as a risk factor for Alzheimer's disease, New Eng J Med 25 (2002), 2007.
27. T.B. Shea and E. Rogers, Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: augmentation by vitamin E, Molecular Brain Res 108 (2002), 1-6.
28. T.B. Shea, J. Lyons-Wieler and E. Rogers, Homocysteine, folate deprivation and Alzheimer's disease, J Alz dis 4 (2002), 261-268
29. M.A. Smith, C.A. Rottkamp, A. Nunomura, A.K. Raina and G. Perry, Oxidative stress in Alzheimer's disease, Biochim Biophys Acta 1502 (2000), 139-144.
30. D.A. Snowdon, C.L. Tully, C.D. Smith, D. Riley and W. Markesbery, Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study, Am J Clin Nutr 71 (2000), 993-998.
31. L.J. Thal, R.G. Thomas, R. Mulnard, M. Sano, M. Grundman and L. Schneider, Estrogen levels do not correlate with improvement in cognition, Arch Neurol 60 (2003), 209-212.
32. P.M. Ueland, S. Hustad, J.M. Schneede, H. Refsum and S.E. Vollset, Biological and clinical implications of the MTHFR C677T polymorphism, Trends Pharm Sci 22 (2001), 195-201.
33. H.-X. Wang, A. Wahlin, H. Basun, J. Fastom, B. Winblad and L. Fratiglioni, Vitamin B 12 and folate in relation to the development of Alzheimer's disease, Neurol 56 (2001), 1188-1194.
34. R.A. Wevers, S.I. Hansen, J.L.MvH. Hubar, J. Holm, M. Hoier-Madsen and P.J.H. Jongen, Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system, J Neurol Neurosurg Psych 57 (1994), 223-226.
35. A.R. White, X. Huang, M.F. Jobling, C.H. Barrow, K. Beyreuther, C.L. Masters, A.I. Bush and R. Cappai, Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways, J Neurochem 76 (2001), 1509-1520.
36. J. Zuttiun, Congenital effors of folate metabolism, Baill Clin Haematol 8 (1995), 603-616.